Talphera Total Revenue Over Time
| TLPH Stock | 0.64 0.02 3.23% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Talphera Performance and Talphera Correlation. Talphera |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 0.018 | Return On Assets (0.47) | Return On Equity (1.18) |
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Talphera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Revenue Analysis
Compare Talphera and related stocks such as Emergent Biosolutions, Neurocrine Biosciences, and Teva Pharma Industries Total Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBS | 45.3 M | 273.4 M | 281.9 M | 312.7 M | 450.1 M | 522.8 M | 488.8 M | 560.9 M | 782.4 M | 1.1 B | 1.6 B | 1.8 B | 1.1 B | 1 B | 560.8 M |
| NBIX | 19.2 M | 77.4 M | 53.1 M | 2.9 M | 0.0 | 19.8 M | 15 M | 161.6 M | 451.2 M | 788.1 M | 1 B | 1.1 B | 1.5 B | 1.9 B | 2 B |
| TEVA | 91.2 M | 18.3 B | 20.3 B | 20.3 B | 20.3 B | 19.7 B | 21.9 B | 22.4 B | 18.9 B | 16.9 B | 16.7 B | 15.9 B | 14.9 B | 15.8 B | 9.5 B |
| HLN | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 8.5 B | 9.9 B | 9.5 B | 10.9 B | 11.3 B | 11 B |
Talphera and related stocks such as Emergent Biosolutions, Neurocrine Biosciences, and Teva Pharma Industries Total Revenue description
Total revenue comprises all receipts Talphera generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.My Equities
My Current Equities and Potential Positions
| Talphera | TLPH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 0.64
Check out Talphera Performance and Talphera Correlation. For more detail on how to invest in Talphera Stock please use our How to Invest in Talphera guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Talphera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.